HC Wainwright & Co. Reiterates Buy on Belite Bio, Maintains $200 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 85.1%

Neg 0% Neu 85.1% Pos 0%

HC Wainwright & Co. analyst Yi Chen reiterates Belite Bio (NASDAQ:BLTE) with a Buy and maintains $200 price target.

Comments

No comments yet. Be the first!

HC Wainwright &amp; Co. Reiterates Buy on Belite Bio, Maintains $200 Price Target